Biodegradable drug delivery vascular stent

Details Biodegradable drug delivery vascular stent Biodegradable drug delivery vascular stent

2005-03-22

2005-03-22

Isabella, David J. (Department: 3738)

Prosthesis (i.e., artificial body members), parts thereof, or ai

Arterial prosthesis

Drug delivery

C623S001220, C623S901000, C606S195000, C424S425000, C424S426000

Reexamination Certificate

active

06869443

ABSTRACT:
A stent includes a main body of a generally tubular shape for insertion into a lumen of a vessel of a living being. The tubular main body includes a substantially biodegradable matrix having collagen IV and laminin that enclose voids within the matrix. The tubular main body also includes a biodegradable strengthening material in contact with the matrix to strengthen the matrix. The tubular main body is essentially saturated with drugs.

REFERENCES:
patent: 2836181 (1958-05-01), Tapp
patent: 4057537 (1977-11-01), Sinclair
patent: 4470407 (1984-09-01), Hussein
patent: 4550447 (1985-11-01), Seiler, Jr. et al.
patent: 4690684 (1987-09-01), McGreevy et al.
patent: 4740207 (1988-04-01), Kreamer
patent: 4768507 (1988-09-01), Fischell et al.
patent: 4770176 (1988-09-01), McGreevy et al.
patent: 4799479 (1989-01-01), Spears
patent: 4820298 (1989-04-01), Leveen et al.
patent: 4830003 (1989-05-01), Wolff et al.
patent: 4886062 (1989-12-01), Wiktor
patent: 4907336 (1990-03-01), Gianturco
patent: 4950227 (1990-08-01), Savin et al.
patent: 4950258 (1990-08-01), Kawai et al.
patent: 4990155 (1991-02-01), Wilkoff
patent: 4994033 (1991-02-01), Shockey et al.
patent: 5024671 (1991-06-01), Tu et al.
patent: 5032679 (1991-07-01), Brandley et al.
patent: 5061281 (1991-10-01), Mares et al.
patent: 5092841 (1992-03-01), Spears
patent: 5092885 (1992-03-01), Yamada et al.
patent: 5100429 (1992-03-01), Sinofsky et al.
patent: 5108417 (1992-04-01), Sawyer
patent: 5116318 (1992-05-01), Hillstead
patent: 5139480 (1992-08-01), Hickle et al.
patent: 5147370 (1992-09-01), McNamara et al.
patent: 5201778 (1993-04-01), Brotzu et al.
patent: 5234457 (1993-08-01), Andersen
patent: 5344425 (1994-09-01), Sawyer
patent: 5376276 (1994-12-01), Li
patent: 5500013 (1996-03-01), Buscemi et al.
patent: 5575815 (1996-11-01), Slepian et al.
patent: 5769883 (1998-06-01), Buscemi et al.
patent: 5968092 (1999-10-01), Buscemi et al.
patent: 6121027 (2000-09-01), Clapper et al.
patent: 6129757 (2000-10-01), Weadock
patent: 6387124 (2002-05-01), Buscemi et al.
patent: 6387379 (2002-05-01), Goldberg et al.
patent: 6596296 (2003-07-01), Nelson et al.
patent: 20030175410 (2003-09-01), Campbell et al.
“Biosynthesis of Heparin and Heparan Sulfate,” Ulf Lindahl and Lena Kjellen, Biology of Proteoglycans, 1987.*
“Molecular Biology of Proteoglycans and Link Proteins,” Linda J. Sandell, Biology of Proteoglycans, 1987.*
“Blood, Coagulants and Anticoagulants,” Encyclopedia of Chemical Technology, vol. 4, Third Edition.

Affiliated with

Also associated with

Rating

Biodegradable drug delivery vascular stent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biodegradable drug delivery vascular stent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biodegradable drug delivery vascular stent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3442621